Drug Description in Trials / DrugBank / KEGG DRUG /
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | Copper | 1件: Copper Copper | - | - | - | 4件: 2 2, 169, 170, 171 |
| 2 | Copper Histidinate | 1件: Copper Copper | - | - | - | 1件: 169 169 |
| 3 | Copper Histidine | 2件: Copper Copper,Histidine | 1件: D00032
D00032
| - | - | 2件: 169 169, 170 |
| 4 | Diethyldithiocarbamate | 1件: Ditiocarb Ditiocarb | - | - | - | 1件: 169 169 |
| 5 | Droxidopa | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 |
| 6 | Histidine | 1件: Histidine Histidine | 1件: D00032
D00032
| - | - | 3件: 13 13, 169, 170 |
| 7 | Long Term Follow-Up | - | - | - | - | 1件: 169 169 |